nullCardiac Surgery in China
Current status and
Some CharacteristicsCardiac Surgery in China
Current status and
Some CharacteristicsZhu Xiaodong
Fuwai Cardiovascular Institute 2004.10CHINA:
A developing country with a huge
population of 1.3 billions*CHINA:
A developing country with a huge
population of 1.3 billions*Even the growing pace of the population has gradually slowed down
Increasing rate: still as high as 0.7% per year
Out of 16.6millions of newborns
>100,000 babies with CHD (6.7 ‰) are added each year
* Report of the Ministry of Public Health. 2001
Potential Patients who may need cardiac surgery:Potential Patients who may need cardiac surgery:Myocardial infarction 2.967 millions*
Rheumatic valvular disease 2.235 millions
Congenital heart disease 1.80-1.95 millions
(6.7‰ in newborns)
Idiopathic cardiomyopathy 1.60 millions**
Others
Total >8millions
*Gu Dongfeng. Prevalence of cardiovascular diseases in China 42nd conference on cardiovascular disease epidemiology and prevention 2002.04 Hawaii
**Yubao Zou et al. Am J Medicine 2004,116:14-8Distribution of different kinds of heart operationsDistribution of different kinds of heart operationsIn general :
Number one:Congenital (60%-65%)
Second: Valve surgery (20%-25%);
Third:Coronary surgery (10%-20%)
*CABG >50% in few units
Fuwai Hospital: (1977~2003)
25,279 cases
CongenitalCABGValvesCABG has gradually
surpassed valve operationsCABG has gradually
surpassed valve operationsFu-Wai HospitalLimited Medical resources
The capacity of cardiac surgeryLimited Medical resources
The capacity of cardiac surgeryThere are about 900 cardiothoracic units
(including about 500 heart units)
Nearly 80,000 heart operations in 2003
13 big heart centers (>1000 open hearts/year)
(阜外, 安贞, 新华, 上海中山, 长海, 武汉协和, 亚心, 霍英东, 湘雅, 沈军区, 华西, 四医大, 三医大…)
Our mission:
Millions of heart operations /yOur mission:
Millions of heart operations /y
Another hundred of heart centers as big as Fu-wai heart hospital or as good as THI should be built up in China.
A whole network of service and a reliable insurance system nationwide also should be established.1. Increasing number of baby-patients1. Increasing number of baby-patients苏肇伉:心血管病国际论坛2004.09 北京characteristic349 operations of complicated congenital heart diseases.
57% under 6 months of age
徐志伟)*: *晚期心脏病外科治疗研讨会,上海 2004
Surgery of Congenital Heart Disease2. More complicated anomalies 2. More complicated anomalies About 25% are complicated cases
Overall operative mortality ------10% to 15%
Unlike western countries, most cyanotic cases are Tetralogy of Fallot ( mortality 1.1%-5%) Because of small percentage of neonates.
In a series of 115 neonates of congenital heart disease nearly 50% of them were TGA*
*苏肇伉:心血管病国际论坛2004.09 北京
Surgery of Congenital Heart DiseaseContinueImprovement of Coronary SurgeryImprovement of Coronary SurgeryFirst CABG 1974 Guo Jiaqiangnull
10%-20% of total number of heart operations in general
(in few heart centers, the percentage of CABG has been as high as 50%)
Operative mortality:
2%-3% in big centersThe number of CABGFWHnullOff-pump Coronary bypass
Number of OPCAB has been increasing
Out of total number of CABG, 20%-30% are off-pump in general.
A series of 1198cases (79.5% of total CABG) Mortality 1.2% Early results were satisfactoryIt was 46% at FWH 2003Promotion & competition
from PTCAPromotion & competition
from PTCA PTCA has been increasing much faster in recent years
Especially since drug-eluting stent
came into use.
Sirolimus eluting stent has been widely used in China. PTCA was one and a half times more than CABG at FWH
PTCA is still facing “re-stenosis”
Guideline update: severe proximal LAD stenosis
and/or 3-vessel disease may achieve improved
survival with CABG.
So, Surgeons will have more complicated or restenosis cases.Etiology of Valve Disease Etiology of Valve Disease The majority of heart valve disease was rheumaticCongenitaldegenerative(Fu Wai Hospital 1997~2003)Heart Valve Surgery:nullTechnically popularized MVR >AVR
Valve prosthesis:
Mechanical >90% : G-K,Lanzhou,St.Jude,
MAFW 97-03Valve Replacement First case -- 1965 Cai Yongzhi, Tissue valves: much less (because of younger age and re-operation..)Home made Pericardial Since 1976, The longest:AVR-21y;MVR-21y Valve Repair Valve RepairAmong the mitral valve operations
Only around 10%----repair
A variety of plastic rings are used
Alfieri edge to edge technique: for ischemic
mitral regurgitation
TV: Exclusively --- reconstruction technique
De Vega or Ring
AV repair: Only limited indications
AS, Prolapse of leaflets, AV-ring dilatation
Minimally Invasive Procedures
for heart valve surgeryMinimally Invasive Procedures
for heart valve surgeryRight thoracotomy
Partial sternotomy
Beating heart with ECC
Endoscopy assisted
11%Fu Wai Hospital Data:1997~2000)null Surgery of Aortic AneurysmThe aortic arch replacement was started ----1960th
The operative mortality of dissecting aneurysm
has come down to 6.8%-10.1% recently.
Surgery + Intra-vascular intervention
Elephant procedure 60 cases (FWH 1997-2003)
Ascending aorta and total arch replacement combined with stented graft implantation into the descending aorta Surgical Treatment for
End stage Heart Failure Surgical Treatment for
End stage Heart FailureBasically there are 3 approaches:
1. Heart, heart-lung transplantation
※ Very effective and important
※ Very limited number so far.
Heart and heart-lung transplants are less
than 200cases
※ More heart centers have started heart transplant
in many provinces recently.null A new design at FWH The 3rd Generation of VAD
Megnetic activated
subaortic pump Surgical Treatment for End stage Heart Failure continue2. Ventricular assist device(VAD)
Novacor, BAS, Meados, Berlin Heart
It is too expensive and complex technically Surgical Treatment for
End stage Heart FailureSurgical Treatment for
End stage Heart Failure3. Cell transplantation
It is now only in the stage of basic research, and very few primary clinical trial.
Mostly: Using marrow stem cells (put stem cells into coronary artery)ContinueSummarySummaryChina, as a developing country, there are some characteristics in cardiac surgery.
1. huge and continue growing patient population.
2. Increasing coronary heart disease, CABG is moving
to the second largest group in cardiac surgery.
3. Rheumatic is the main cause of heart valve disease.
Very small percentage of tissue valves are used.
4. The majority of cyanotic congenital heart disease is
Tetralogy of Fallot
Summary continueSummary continueCardiac surgery in China is now at its full speed of development.
From the point of technology in the field of coronary and valvular surgery, there is no significant gap compared with developed countries.
As to neonate heart surgery and aortic surgery, we have a rather long way to go. nullLastly, I hope the information I provided here may encourage you to extend your practice or collaboration in the near future.nullThank
you